Pages that link to "Q44809949"

The following pages link to Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol (Q44809949):

Displaying 13 items.

• Oral contraceptives containing drospirenone for premenstrual syndrome (Q24203717) (← links)
• Oral contraceptives containing drospirenone for premenstrual syndrome (Q24240981) (← links)
• Oral contraceptives containing drospirenone for premenstrual syndrome (Q24242351) (← links)
• The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment (Q24561815) (← links)
• Psychological, social, and spiritual effects of contraceptive steroid hormones (Q35953812) (← links)
• Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol. (Q36642976) (← links)
• A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms (Q36720116) (← links)
• Added benefits and user satisfaction with a low-dose oral contraceptive containing drospirenone: results of three multicentre trials (Q37365590) (← links)
• Beyaz®: An Oral Contraceptive Fortified with Folate (Q37968645) (← links)
• Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC). (Q47376748) (← links)
• Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats (Q47779958) (← links)
• Positive correlation between anxiety severity and plasma levels of dehydroepiandrosterone sulfate in medication-free patients experiencing a major episode of depression (Q50918794) (← links)
• The brain as a target of hormonal contraceptives: Evidence from animal studies (Q90718457) (← links)